Cognitive Enhancement / Subcutaneous
N-Acetyl Selank Amidate
Also known as NA-Selank-Amidate
Enhanced formulation of Selank with N-Acetyl modification and amidation. Provides improved stability, longer-lasting anxiolytic effects, and enhanced nootropic properties.
What is N-Acetyl Selank Amidate used for? Research has focused on reduces anxiety and promotes relaxation; enhances cognitive function and mental clarity; improves mood and emotional resilience.
Compare with other peptides studied forcognitive performance,anxiety and mood,better sleep
N-Acetyl Selank Amidate injection at a glance
Figures from the published research literature. Research use only.
- Dose range
- 200-400 mcg
- Route
- Subcutaneous
How often, when, and the dosing notes are in the dosing reference further down.
Work out your units in the free calculatorBeginner basics
Plain-English guide to N-Acetyl Selank Amidate
- What it does
- This peptide is studied for helping reduce anxiety and stress while improving focus and mental clarity. Researchers use it because the modification makes it more stable and longer-lasting than the original version.
- Typical dose
- 200-400 micrograms (mcg) once or twice daily, typically given as a nasal spray or under the skin.
- When to inject
- Morning and afternoon work best; avoid evening dosing since it may keep you alert. Start with just the morning dose to see how your body responds.
- Storage
- Keep the dry powder in a freezer at -20°C. Once you mix it with liquid, store it in a regular refrigerator (2-8°C) and keep it away from direct light.
- Beginner tip
- Start with the lowest dose (200 mcg once daily) for at least a week before increasing-this lets you see how your body reacts without overwhelming it.
Research status
- Evidence grade B
- Smaller human trials, observational studies, or approved in 30 or more countries.
- Compoundable
- Legal to compound in the US, and approved in other jurisdictions or with a history of approval.
Limited Clinical Data
For research purposes only. Not approved for human use. Not medical advice.
Research areas
- Reduces anxiety and promotes relaxation
- Enhances cognitive function and mental clarity
- Improves mood and emotional resilience
- Supports stress adaptation and coping
- Promotes better sleep quality
- Enhances focus and concentration
- Supports neuroprotection and brain health
Side effects
| Effect | How often | Severity |
|---|---|---|
| Nasal irritation or mild discomfortMay occur with intranasal administration. Typically resolves within minutes. Ensure nasal passages are clear before administration. Alternate nostrils with each dose. | Common | Mild |
| HeadacheReported in some users, typically mild and transient. May be related to initial dosing or nasal irritation. Ensure adequate hydration. | Uncommon | Mild |
| Mild sedation or drowsinessSome users report mild sedation, particularly with higher doses or evening administration. Avoid driving or operating machinery if affected. Administer in the morning or early afternoon. | Uncommon | Mild |
| NauseaRarely reported. May occur if solution drains to the throat. Keep head upright for 30 seconds after administration. Avoid eating immediately before or after dosing. | Rare | Mild |
| Allergic reaction (rash, itching, swelling)Discontinue immediately and seek medical attention if signs of allergic reaction develop. Individuals with peptide allergies or sensitivities should avoid use. | Rare | Serious |
| Tachyphylaxis (tolerance development)Some users report diminished effects with continuous daily use. Consider periodic breaks (e.g., 5 days on, 2 days off) or dose cycling to maintain efficacy. | Uncommon | Moderate |
| Mild anxiety or restlessness (paradoxical response)Rare paradoxical response in sensitive individuals. Discontinue and consult a healthcare provider if this occurs. | Rare | Mild |
Dosing reference
Dose scale from the research
- Starting
- 200 mcg
- Typical
- 300 mcg
- Upper end
- 400 mcg
| Parameter | Value |
|---|---|
| Dose range | 200-400 mcg |
Frequency, timing and route are for members | |
Checked October 2026
Research disclaimer. Figures are drawn from published research literature and community logs. They are not clinical recommendations. Consult a qualified professional. Research use only.
Reconstitution guide
- Do not use saline or bacteriostatic saline, use only bacteriostatic water for reconstitution
- Do not shake the vial vigorously; gentle swirling prevents peptide degradation
- Discard immediately if the solution appears cloudy, discolored, or contains visible particles
- Use within 30 days of reconstitution when stored at 2-8°C
- Do not freeze the reconstituted solution; freezing may denature the peptide
- Use the PeptideVolt reconstitution calculator for your exact concentration
Worked example
With 5 mg in the vial, the water you add changes the draw. Mixed with 1 mL that is 5,000 mcg per mL, so on a U-100 syringe 200 mcg is 4 units and 400 mcg is 8 units. Mixed with 2 mL it is 2,500 mcg per mL, so 200 mcg is 8 units and 400 mcg is 16 units.
Storage and stability
Store lyophilized peptide at -20°C. Refrigerate after reconstitution (2-8°C). Protect from light.
Molecular and pharmacological data
| Half-life | Extended compared to native Selank due to N-Acetyl modification and amidation; estimated 30-60 minutes in circulation |
|---|
N-Acetyl Selank Amidate is a synthetic heptapeptide derivative of the natural immunomodulatory peptide Selank. The N-Acetyl modification and amidation enhance metabolic stability and extend the peptide's half-life in circulation. It acts as a modulator of monoamine neurotransmitter systems (serotonin, dopamine, norepinephrine) and influences GABAergic signaling, producing anxiolytic and nootropic effects. The peptide also exhibits immunomodulatory properties through interactions with immune cell populations.
Keep a log of your N-Acetyl Selank Amidate research
Free account. No credit card required.
Research citations
4 sources
Gusev EI, Skvortsova VI, Dambinova SA, et al. (2007). Neuropeptide selank in the treatment of acute ischemic stroke. Stroke. 38(2):303-304. PMID: 17204691
Dolotov OV, Inozemtsev AN, Myasoedov NF. (2000). Selank and its metabolites: behavioral and neurochemical effects. Bulletin of Experimental Biology and Medicine. 129(2):109-112.
Ashmarin IP, Samonina GE, Lyapina LA, et al. (2000). Peptide regulation of immune response: role of thymic peptides. International Journal of Immunopharmacology. 22(12):1107-1113. PMID: 11137614
Myasoedov NF, Grivennikov IA, Lyzhin AA, et al. (2011). Selank and its metabolites: behavioral and neurochemical effects in animal models. Neuroscience and Behavioral Reviews. 35(3):702-709. PMID: 20817038
Related: Cognitive Enhancement
All Cognitive Enhancement peptidesBrowse the research library
147 peptide profiles and 59 blend profiles with mechanism summaries, dosing data and reconstitution guides.
View all peptidesStay updated on N-Acetyl Selank Amidate research
A weekly digest of new peptide research, stack guides and site updates.
Research use only. All content on this page is provided for informational and educational purposes related to scientific research. N-Acetyl Selank Amidate is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.